Melanoma
Article
COVID-19 prompts ‘democratization’ of cancer trials
Dr. Alan Lyss reviews a panel discussion about how COVID-19 has affected cancer research.
News
Durable response 5 years after adjuvant combo in melanoma
Plateaus observed with relapse and distant metastasis-free survival suggest that true disease cures are being achieved with treatment.
News
Immunotherapy should not be withheld because of sex, age, or PS
News
Aspirin may accelerate cancer progression in older adults
Article
Artificial intelligence matches cancer genotypes to patient phenotypes
Conference Coverage
Study: Immune checkpoint inhibitors don’t increase risk of death in cancer patients with COVID-19
The mortality rate was 8% among patients who received immune checkpoint inhibitors, which is comparable with the overall mortality rate among...
News
OK to treat many cancer patients despite pandemic, says ESMO
ESMO recommends against stopping or delaying cancer treatment that can impact survival.
Conference Coverage
Americans getting more sunburns
But indoor tanning has faded in popularity in the United States.
Conference Coverage
CCC19, other registries help define COVID/cancer landscape
New data from CCC19 show an increased risk of death from COVID-19 among non-Hispanic black cancer patients and patients with hematologic...
Conference Coverage
Personalized cancer vaccine may enhance checkpoint inhibitor activity
